Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? (Q33578847)

28 July 2017

Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? (English)

1 reference

28 July 2017

1 reference

polymyalgia rheumatica

1 reference

van der Veen MJ

1

1 reference

28 July 2017

Dinant HJ

2

1 reference

28 July 2017

van Booma-Frankfort C

3

1 reference

28 July 2017

van Albada-Kuipers GA

4

1 reference

28 July 2017

Bijlsma JW

5

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 April 1996

1 reference

Annals of the Rheumatic Diseases

28 July 2017

1 reference

28 July 2017

55

1 reference

28 July 2017

4

1 reference

28 July 2017

218-223

1 reference

The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010141

Immunopathogenesis, diagnosis, and treatment of giant cell arteritis, temporal arteritis, polymyalgia rheumatica, and Takayasu's arteritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010141

Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010141

Giant cell (cranial) arteritis: a clinical review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010141

Polymyalgia rheumatica and corticosteroids: how much for how long?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010141

Temporal arteritis: clinical aids to diagnosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010141

Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010141

Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010141

The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010141

Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010141

Interpretation and power of a pooled index

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010141

The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010141

Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1010141

Duration of corticosteroid therapy in giant cell arteritis

31 October 2018

1 reference

12 December 2020

Long-term follow-up of polymyalgia rheumatica: evidence for synovitis

1 reference

12 December 2020

Polymyalgia rheumatica. Duration of therapy and long-term outcome

1 reference

12 December 2020

Prevention of blindness in giant cell arteritis by corticosteroid treatment

1 reference

12 December 2020

Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate

1 reference

12 December 2020

Methotrexate treatment in the management of giant cell arteritis

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.55.4.218

1 reference

28 July 2017

1 reference

28 July 2017

1 reference